Skystar Bio-Pharmaceutical Company, a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it has gained exclusive rights to sell and market its aquaculture vaccine through 2024.
Skystar bio-pharmaceutical gains exclusive rights to sell and market aquaculture vaccine through 2024